Clinical Trial Update: A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of follow-up serial infusions of nesiritide (Natrecor) for heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Heart Failure, Congestive | Phase 2 | Status: COMPLETED